Dr. Matt E Koepke is a Charleston, South Carolina based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 198 Rutledge Avenue, Suite 4, Charleston. Patients can reach him at 843-853-5859.
Dr. Matt E Koepke deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Matt E Koepke speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Matt E Koepke
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.D.S.
Accepts Medicare Assignment:
May Accept
Practice Address:
198 Rutledge Avenue, Suite 4, Charleston, South Carolina, 29403
Phone:
843-853-5859
Fax:
843-853-5861
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
2466741715
Enrollment ID:
I20160510001754
NPI Number:
1386909109
NPI Enumeration Date:
09 Jul, 2012
NPI Last Update On:
20 Oct, 2016
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
198 Rutledge Avenue, Suite 4 Charleston, South Carolina
Zip:
29403
Phone Number:
843-853-5859
Fax Number:
843-853-5861
Patients can reach Dr. Matt E Koepke at 198 Rutledge Avenue, Suite 4, Charleston, South Carolina or can call to book an appointment on 843-853-5859. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.